Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT02095743

Unknown

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (EPIC)

Early Stage Breast Carcinoma
NCT01797120

Completed

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI (PrE0102)

Metastatic Breast Cancer
NCT02379585

Terminated

Fasting on Newly Diagnosed Breast Cancer (STEFNE)

HER2-positive Breast Cancer
NCT03401359

Unknown

The Resistance and Immune Response to Palbociclib in Breast Cancer

Breast Cancer Stage IV
NCT02077998

Completed

Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Stage IV Breast Cancer
NCT03385200

Unknown

KVUS at Neoadjuvant CTx of Breast Cancer

Early Primary Breast Cancer
NCT03373708

Unknown

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Breast Cancer | Chemotherapy | Endocrine Breast Diseases
NCT01965522

Completed

Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer (MELO-D)

Early Stage Breast Cancer
NCT00165243

Completed

Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer

Early-Stage Breast Cancer
NCT02322853

Terminated

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (OLYMPE)

Metastatic Breast Cancer | Postmenopausal
NCT02213744

Terminated

MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients (HERMIONE)

Breast Cancer | HER2 Positive Breast Cancer
NCT00617370

Completed

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Breast Cancer | Adenocarcinoma of the Breast
NCT01837563

Terminated

Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer

Locally Advanced Breast Cancer
NCT01688479

Completed

Trial Comparing Calendula Officinalis With Aqueous Cream "Essex" to Treat Skin Reactions From Radiotherapy of Breast Cancer

Postoperative Radiotherapy Breast Cancer
NCT01067989

Terminated

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Chemotherapy | Breast Cancer, Metastatic
NCT01906112

Withdrawn

Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.

Carcinoma Breast Stage IV
NCT01121549

Terminated

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

Invasive Early Breast Cancer
NCT01531764

Terminated

BIBW 2992 (Afatinib) and Vinorelbine

Carcinoma Breast Stage IV
NCT00788489

Completed

A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy (PETLAB)

Locally Advanced Breast Cancer
NCT00236899

Completed

Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC

Metastatic Breast Cancer (MBC)
NCT00337064

Unknown

Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women

Stage I Breast Cancer
NCT00189670

Completed

Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer

Node Positive Breast Cancer
NCT07044310

Recruiting

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma
NCT01281150

Completed

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma
NCT04054557

Completed

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7
NCT02876640

Terminated

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Early Stage Breast Carcinoma
NCT06961955

Recruiting

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer (FAST NOVEMBER)

Breast Cancer | Ductal Breast Carcinoma in Situ | Invasive Carcinoma of Breast
NCT06786026

Recruiting

QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

TNBC, Triple Negative Breast Cancer
NCT06338644

Not yet recruiting

Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients. (Palbociclib)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
NCT06254066

Not yet recruiting

Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer

Female Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
NCT06112613

Recruiting

Mobile Health for Adherence in Breast Cancer Patients

Breast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast Carcinoma
NCT03165487

Active, not recruiting

Comparison of the Breast Tumor Microenvironment

Triple Negative Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast
NCT07018427

Active, not recruiting

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Breast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HR+, HER2-, Advanced Breast Cancer
NCT05209529

Withdrawn

Chemo-free BRCA-targeted Neoadjuvant Strategy

BRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
NCT05945290

Completed

Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Early Stage Breast Carcinoma
NCT07003009

Recruiting

Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer

Breast Carcinoma | Breast Cancer Metastatic
NCT05710328

Active, not recruiting

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | HER2-Positive Breast Carcinoma
NCT04245176

Completed

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Breast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast Cancer
NCT01957514

Terminated

Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy (ITOMIC)

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7
NCT04209010

Completed

Immediate Breast Reconstruction With Acellular Dermal Matrix

Breast Cancer | Mammaplasty | Breast Carcinoma in Situ | Acellular Dermis
NCT07016399

Recruiting

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Triple-Negative Breast Carcinoma
NCT06999798

Recruiting

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma
NCT06042569

Recruiting

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma
NCT01276054

Terminated

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

Lymphedema | Stage II Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Recurrent Breast Cancer
NCT07558343

Not yet recruiting

Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2 (MATADOR2)

Male Breast Cancer
NCT07549139

Not yet recruiting

Overcoming Racial Disparities in Screening Mammography

Breast Cancer | Cancer of the Breast
NCT07311993

Recruiting

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Breast Cancer
NCT07122713

Recruiting

Definitive Radiation Therapy for Inoperable Breast Cancer (DEFINE)

Breast Cancer | Breast Adenocarcinoma
NCT06825949

Not yet recruiting

A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients

Breast Cancers
NCT06429761

Recruiting

Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients (STRIDE)

BREAST CANCER

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations